… the creation of transformative RNA therapies for severe genetic rare diseases, today reported its financial results … program in the United States providing no-cost genetictesting and genetic counseling for individuals with a …
… the creation of transformative RNA medicines for severe genetic rare diseases, today reported its financial results … We advanced two additional programs to Phase 1/2 clinical testing – QR-421a for Usher syndrome and non-syndromic RP, …